Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History $1.46 -0.01 (-0.34%) As of 02:22 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aclaris Therapeutics Stock Price Performance The Aclaris Therapeutics (ACRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 14.57%, with a year-to-date return of -41.33%. In the past month, the stock has decreased 4.90%, reflecting recent market activity. As of the latest close, Aclaris Therapeutics traded at $1.46 with a market cap of $158.09 million and volume of 567,998 shares. Five years ago, the stock traded at $1.74, representing a 16.38% decrease over that period. At the time, it had a market cap of $70.33 million and a volume of 534,247 shares. Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.69%1 Month Performance-4.90%3 Month Performance+18.29%Year-To-Date Performance-41.33%1 Year Performance+14.57%5 Year Performance-16.38% ACRS Stock Chart for Tuesday, July, 8, 2025 ACRS Chart by TradingView Aclaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$1.45$1.46+1.04%$1.50$1.44567,998 shs$158.09 million07/04/2025$1.45$1.45$1.49$1.44402,410 shs$156.47 million07/03/2025$1.45$1.45-0.34%$1.49$1.44402,410 shs$156.47 million07/02/2025$1.41$1.45+2.84%$1.52$1.39733,074 shs$157.01 million07/01/2025$1.42$1.41-0.70%$1.47$1.38715,066 shs$152.68 million06/30/2025$1.47$1.42-3.40%$1.47$1.39965,844 shs$153.76 million06/27/2025$1.56$1.47-5.77%$1.63$1.4211.53 million shs$159.17 million06/26/2025$1.63$1.56-4.29%$1.66$1.55991,432 shs$168.92 million06/25/2025$1.52$1.63+7.24%$1.63$1.54947,692 shs$176.50 million06/24/2025$1.39$1.52+9.35%$1.52$1.39681,359 shs$164.59 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$1.45$1.39-4.14%$1.46$1.341.47 million shs$150.51 million06/20/2025$1.42$1.45+2.11%$1.45$1.40887,057 shs$157.01 million06/19/2025$1.42$1.42$1.46$1.37738,101 shs$153.76 million06/18/2025$1.40$1.42+1.43%$1.46$1.37738,101 shs$153.76 million06/17/2025$1.44$1.40-2.78%$1.49$1.40522,832 shs$151.59 million06/16/2025$1.47$1.44-2.04%$1.54$1.44605,826 shs$155.93 million06/13/2025$1.53$1.47-3.92%$1.55$1.47469,573 shs$159.17 million06/12/2025$1.57$1.53-2.55%$1.57$1.52420,503 shs$165.67 million06/11/2025$1.51$1.57+3.97%$1.59$1.48846,103 shs$170.00 million06/10/2025$1.49$1.51+1.34%$1.55$1.45298,956 shs$163.50 million06/09/2025$1.53$1.49-2.61%$1.55$1.47786,877 shs$161.34 million Related Companies Stoke Therapeutics Stock Chart Sana Biotechnology Stock Chart Maravai LifeSciences Stock Chart Urogen Pharma Stock Chart Autolus Therapeutics Stock Chart ChromaDex Stock Chart Cidara Therapeutics Stock Chart Arbutus Biopharma Stock Chart Evolus Stock Chart Upstream Bio Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACRS Stock Alerts